Dapagliflozin reduced mortality risk in aortic stenosis patients undergoing TAVI: Study
Dapagliflozin reduced mortality risk in aortic stenosis patients undergoing TAVI: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link